COVID-19 疫情期间 HIV 照护创新:强化终结 HIV 流行倡议的政策文件
美国感染病学会与 HIV 医学协会发布政策文件,指出 COVID-19 疫情虽减少面对面就诊,但加速了远程医疗、药物配送到家及 Ryan White HIV/AIDS 项目服务灵活性等替代方案,改善可及性;需长期政策保留这些模式以推进终结 HIV 流行倡议。
要点
- 疫情加速远程医疗与药物配送等 HIV 照护替代模式。
- 需长期政策保留疫情中改善可及性的创新选项。
- 这些新照护范式或可为其他慢性病提供参考。
核心结论
- COVID-19 疫情加速了 HIV 照护替代方案的推广,需长期政策保留以推进终结 HIV 流行倡议。
研究设计与样本
- 美国感染病学会与 HIV 医学协会发布的政策文件。
主要发现
- 疫情减少面对面就诊并引发照护中断担忧,但促进了远程医疗、药物配送到家及 Ryan White 项目服务灵活性等选项。
- 许多替代方案在疫情期间改善了照护可及性,其结局仍需研究。
关键数值与推荐
- 终结 HIV 流行倡议目标为 2030 年前美国新发感染减少 90%。
临床怎么用
- 临床可借鉴疫情中远程医疗、药物配送及服务灵活性等模式改善 HIV 照护可及性。
- 需研究这些替代方案的结局,并推动长期政策保留有效选项。
局限性
- 替代方案的结局尚未充分研究,需进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The goal of the Ending the HIV Epidemic Initiative is to reduce new infections in the United States by 90% by 2030. Success will require fundamentally changing human immunodeficiency virus (HIV) prevention and care delivery to engage more persons with HIV and at risk of HIV in treatment. While the coronavirus disease 2019 (COVID-19) pandemic reduced in-person visits to care facilities and led to concern about interruptions in care, it also accelerated growth of alternative options, bolstered by additional funding support. These included the use of telehealth, medication delivery to the home, and increased flexibility facilitating access to Ryan White HIV/AIDS Program services. While the outcomes of these programs must be studied, many have improved accessibility during the pandemic. As the pandemic wanes, long-term policy changes are needed to preserve these options for those who benefit from them. These new care paradigms may provide a roadmap for progress for those with other chronic health issues as well.
引用
- Armstrong WS, Agwu AL, Barrette EP, et al. Innovations in Human Immunodeficiency Virus (HIV) Care Delivery During the Coronavirus Disease 2019 (COVID-19) Pandemic: Policies to Strengthen the Ending the Epidemic Initiative-A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clin Infect Dis. 2021. PMID: 33035296. doi:10.1093/cid/ciaa1532
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。